Search PDMR transactions

Notifier
Name
Peter Zonabend
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Peter Zonabend
Position
Styrelseledamot/suppleant
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Oasmia Pharmaceutical AB
LEI code
5493003TZPR4B7QO9L49
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Subscription right Oasmia Pharmaceutical TR SE0013460540 Acquisition 625,000 Quantity 1.29 SEK 25/11/2019 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Oasmia Pharmaceutical TR SE0013460540 Acquisition 25/11/2019 NASDAQ STOCKHOLM AB 625,000 (Quantity) 1.29 SEK
Total: 625,000
<< Back